Page last updated: 2024-08-24

fananserin and mdl 100907

fananserin has been researched along with mdl 100907 in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (33.33)18.2507
2000's3 (50.00)29.6817
2010's0 (0.00)24.3611
2020's1 (16.67)2.80

Authors

AuthorsStudies
Bristow, LJ; Hutson, PH; Rowley, M1
Bentley, G; Blurton, P; Bristow, LJ; Burkamp, F; Castro, JL; Chapman, K; Cheng, SK; Clarkson, R; Cook, GP; Fletcher, SR; Hutson, PH; MacLeod, AM; Marwood, R; O'Connor, D; Patel, S; Shepheard, S; Spinks, D; Tudge, M; van Niel, MB1
Giordanetto, F; Leach, AG; Zachariae, U1
Chen, Z; Collier, T; Fu, H; Liang, SH; Rong, J; Zhou, J1
López-Giménez, JF; Mengod, G; Palacios, JM; Vilaró, MT2

Reviews

2 review(s) available for fananserin and mdl 100907

ArticleYear
Current and novel approaches to the drug treatment of schizophrenia.
    Journal of medicinal chemistry, 2001, Feb-15, Volume: 44, Issue:4

    Topics: Animals; Antipsychotic Agents; Cholinergic Agonists; Disease Models, Animal; Dopamine Antagonists; Enzyme Inhibitors; Excitatory Amino Acid Antagonists; Humans; Mice; Mice, Transgenic; Nitric Oxide Synthase; Receptor, Serotonin, 5-HT2A; Receptors, AMPA; Receptors, Dopamine D2; Receptors, Dopamine D4; Receptors, Metabotropic Glutamate; Receptors, N-Methyl-D-Aspartate; Receptors, Neurotensin; Receptors, Serotonin; Schizophrenia; Serotonin Antagonists

2001
Positron Emission Tomography (PET) Imaging Tracers for Serotonin Receptors.
    Journal of medicinal chemistry, 2022, 08-25, Volume: 65, Issue:16

    Topics: Brain; Humans; Ligands; Positron-Emission Tomography; Radiopharmaceuticals; Receptors, Serotonin

2022

Other Studies

4 other study(ies) available for fananserin and mdl 100907

ArticleYear
4-(Phenylsulfonyl)piperidines: novel, selective, and bioavailable 5-HT(2A) receptor antagonists.
    Journal of medicinal chemistry, 2002, Jan-17, Volume: 45, Issue:2

    Topics: Administration, Oral; Animals; Benzamides; Biological Availability; Brain; Cation Transport Proteins; Cell Line; Cricetinae; DNA-Binding Proteins; Drug Evaluation, Preclinical; Electrocardiography; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Ferrets; Humans; In Vitro Techniques; Male; Microsomes, Liver; Nitriles; Piperidines; Potassium Channels; Potassium Channels, Voltage-Gated; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT2A; Receptors, Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Spiro Compounds; Structure-Activity Relationship; Sulfones; Trans-Activators; Transcriptional Regulator ERG

2002
Side chain flexibilities in the human ether-a-go-go related gene potassium channel (hERG) together with matched-pair binding studies suggest a new binding mode for channel blockers.
    Journal of medicinal chemistry, 2009, Jul-23, Volume: 52, Issue:14

    Topics: Binding Sites; Ether-A-Go-Go Potassium Channels; Humans; Hydrophobic and Hydrophilic Interactions; Ligands; Models, Molecular; Potassium Channel Blockers; Protein Binding; Protein Conformation

2009
Selective visualization of rat brain 5-HT2A receptors by autoradiography with [3H]MDL 100,907.
    Naunyn-Schmiedeberg's archives of pharmacology, 1997, Volume: 356, Issue:4

    Topics: Animals; Autoradiography; Binding, Competitive; Brain; Cyclic S-Oxides; Ergolines; Fluorobenzenes; Guanylyl Imidodiphosphate; In Situ Hybridization; In Vitro Techniques; Ketanserin; Male; Naphthalenes; Piperidines; Protein Binding; Radioligand Assay; Rats; Rats, Wistar; Receptor, Serotonin, 5-HT2A; Receptors, Serotonin; RNA, Messenger; Serotonin Antagonists

1997
[3H]MDL 100,907 labels 5-HT2A serotonin receptors selectively in primate brain.
    Neuropharmacology, 1998, Volume: 37, Issue:9

    Topics: Aged; Aged, 80 and over; Animals; Binding Sites; Binding, Competitive; Brain; Cyclic S-Oxides; Ergolines; Female; Fluorobenzenes; Humans; In Situ Hybridization; Ketanserin; Macaca fascicularis; Male; Naphthalenes; Piperidines; Radioligand Assay; Receptor, Serotonin, 5-HT2A; Receptors, Serotonin; RNA, Messenger; Tritium

1998